Promising Discovery of Beneficial in the Human Gut
Overview
Authors
Affiliations
Ingested dietary fibres are hydrolysed by colon microbiota to produce energy-providing short-chain fatty acids (SCFA) that stimulate anti-inflammatory effects. SCFA-producing bacteria were screened from bacteria isolated from human faeces using bromothymol blue as an acid indicator and gas chromatography for SCFA profiling. The beneficial functions (antagonistic activity, haemolytic activities, antibiotic susceptibility, mucus adherent percentage and toxin gene detection) were evaluated for the top five SCFA-producing bacteria isolated from three healthy volunteers that identified as strains. They produced acetic, propionic, isobutyric, butyric, isovaleric, valeric and caproic acids at average concentrations of 15.9, 1.8, 1.1, 1.9, 1.8, 2.7 and 3.4 mM, respectively. The SCFA production by strains was rapidly increased during the first 8 h of incubation and gradually decreased after 16 h of incubation. All strains showed acid and bile tolerance, resulting in a survival rate greater than 70% with no haemolytic activity, mucus adherence greater than 40% and susceptibility to conventional antibiotics. Hence, the selected strains exhibited promising probiotic properties with neither enterotoxin nor LPS producibility was detected. The present results confirm the existence of friendly and harmless strains in human microbiota as potential probiotics.
Altrawy A, Khalifa M, Abdelmaksoud A, Khaled Y, Saleh Z, Sobhy H Cancers (Basel). 2025; 16(24.
PMID: 39766032 PMC: 11674667. DOI: 10.3390/cancers16244132.
DAngeli F, Granata G, Romano I, Distefano A, Lo Furno D, Spila A Int J Mol Sci. 2024; 25(19).
PMID: 39409022 PMC: 11476408. DOI: 10.3390/ijms251910692.
Public health implications of antibiotic resistance in sewage water: an epidemiological perspective.
Rahim K, Nawaz M, Almehmadi M, Alsuwat M, Liu L, Yu C Bioresour Bioprocess. 2024; 11(1):91.
PMID: 39340706 PMC: 11438758. DOI: 10.1186/s40643-024-00807-y.
The Intestinal Microbiota May Be a Potential Theranostic Tool for Personalized Medicine.
Di Domenico M, Ballini A, Boccellino M, Scacco S, Lovero R, Charitos I J Pers Med. 2022; 12(4).
PMID: 35455639 PMC: 9024566. DOI: 10.3390/jpm12040523.
Chang H, Foo H, Loh T, Lim E, Abdul Mutalib N Front Vet Sci. 2021; 7:602280.
PMID: 33575277 PMC: 7870707. DOI: 10.3389/fvets.2020.602280.